Close Menu

NEW YORK (GenomeWeb) – Sygnis today announced a non-exclusive distribution agreement with Sopachem for the commercialization of TruePrime products.

Under the terms of the agreement, Sopachem will promote, market, sell, and support TruePrime products for primer-free whole genome amplification in Belgium.

TruePrime products use Sygnis' multiple displacement amplification technology based on DNA primase TthPrimPol and Phi29 polymerase.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.